CorMedix (CRMD) Gains from Investment Securities (2011 - 2025)

CorMedix has disclosed Gains from Investment Securities across 13 years of filings, most recently posting $2.0 million for Q4 2025.

• Gains from Investment Securities for Q4 2025 came in at $2.0 million, up 626.83% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.7 million (up 106.31% YoY), and the FY2025 annual result was $1.7 million, down 20.44% from the prior year.
• Gains from Investment Securities came in at $2.0 million for Q4 2025 at CorMedix, down from $2.1 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $25.4 million in Q1 2023 to a low of -$42.7 million in Q3 2023.
• The 5-year median for Gains from Investment Securities is $1.4 million (2021), against an average of $837799.6.
• Across the five-year window, Gains from Investment Securities surged 4725.35% in 2021 and plunged 37361600.0% in 2024, its largest moves.
• CorMedix's Gains from Investment Securities stood at $6.5 million in 2021, then surged by 34.96% to $8.8 million in 2022, then plunged by 100.0% to $1.0 in 2023, then slumped by 37361600.0% to -$373615.0 in 2024, then jumped by 626.83% to $2.0 million in 2025.
• The last three Gains from Investment Securities figures came in at $2.0 million (Q4 2025), $2.1 million (Q3 2025), and $1.9 million (Q2 2025), per Business Quant data.